Ivivi Technologies To Present At Susquehanna Second Annual SIGnificant Options in Healthcare Conference


MONTVALE, N.J., Feb. 28, 2008 (PRIME NEWSWIRE) -- Ivivi Technologies, Inc. (Nasdaq:IVVI) today announced that Andre' DiMino, Vice Chairman and Co-CEO, and David Saloff, President and Co-CEO, are scheduled to present a corporate overview at the Susquehanna Second Annual SIGnificant Options in Healthcare Conference on Tuesday, March 4, 2008 at the W New York Hotel in New York, New York.

Ivivi Technologies' presentation is scheduled for 8:00 a.m. Eastern Time. Individuals interested in listening to the live presentation can participate via webcast by going to the Investor Relations section of the Company's website www.ivivitechnologies.com under Events and Presentations or at http://www.wsw.com/webcast/sig7/ii/. A replay of the webcast will also be available for 90 days.

About Ivivi Technologies, Inc.

Based in Montvale, NJ, Ivivi Technologies, Inc. is a medical technology company focusing on designing, developing and commercializing its proprietary electrotherapeutic technology platform. Ivivi's research and development activities are focused specifically on pulsed electromagnetic field, or PEMF, technology, which, by creating a therapeutic electrical current in injured soft tissue, modulates biochemical and physiological healing processes to help repair the injured tissue and reduce related pain and inflammation. The Company's Electroceuticals have been used in non-invasive treatments for a wide array of conditions, including chronic wounds, pain and edema following plastic and reconstructive surgery and chronic inflammatory disorders.

Forward-Looking Statements

This release contains "forward-looking statements" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 including those related to strategic partnerships and future revenues. Forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, the Company's limited operating history, history of significant and continued operating losses and substantial accumulated earnings deficit, difficulties with its financial accounting controls, the failure of the market for the Company's products to continue to develop, the inability for customers to receive third party reimbursement, the inability to obtain additional capital, the inability to protect the Company's intellectual property, the loss of any executive officers or key personnel or consultants, competition, changes in the regulatory landscape or the imposition of regulations that affect the Company's products and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission, including the Company's Form 10-KSB for the fiscal year ended March 31, 2007. The Company assumes no obligation to update the information contained in this press release.



            

Contact Data